these areas, including increased risk of toxigenic V. cholerae O1 exposure and increased risk of severe outcomes. However, only travel to an area of active cholera transmission was included in the approved recommendation; other risk factors are not mentioned in the recommendation. The proposed definition of an area of active cholera transmission is a province, state, or other administrative subdivision within a country with endemic or epidemic cholera caused by toxigenic V. cholerae O1. It includes areas with cholera activity within the last 1 year that are prone to recurrence of cholera epidemics; it does not include areas where rare sporadic cases have been reported. The vaccine is not routinely recommended for most travelers from the United States, as most travelers from the United States do not visit areas with active cholera transmission. CDC is developing resources for clinicians and travelers to learn which travel destinations may have active cholera transmission.
No information is available about the duration of protection provided by Vaxchora beyond 3-6 months, so the ACIP recommendation does not address reimmunization.
